Chlorine in PDB 6ko9: Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy
Protein crystallography data
The structure of Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy, PDB code: 6ko9
was solved by
T.Matsumoto,
R.Nakashima,
A.Yamano,
K.Nishino,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
18.44 /
2.20
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
43.513,
54.792,
92.224,
74.64,
81.94,
89.98
|
R / Rfree (%)
|
22 /
29.9
|
Other elements in 6ko9:
The structure of Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy
(pdb code 6ko9). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy, PDB code: 6ko9:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 6ko9
Go back to
Chlorine Binding Sites List in 6ko9
Chlorine binding site 1 out
of 4 in the Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl201
b:76.3
occ:1.00
|
CL1
|
A:XZ1201
|
0.0
|
76.3
|
1.0
|
C12
|
A:XZ1201
|
1.8
|
65.7
|
1.0
|
C13
|
A:XZ1201
|
2.6
|
62.7
|
1.0
|
C11
|
A:XZ1201
|
2.8
|
76.1
|
1.0
|
F1
|
A:XZ1201
|
2.8
|
73.6
|
1.0
|
O
|
A:HOH400
|
3.2
|
83.0
|
1.0
|
OH
|
A:TYR59
|
3.3
|
51.1
|
1.0
|
CB
|
A:ALA110
|
3.5
|
55.8
|
1.0
|
C14
|
A:XZ1201
|
3.9
|
77.0
|
1.0
|
NZ
|
A:LYS63
|
4.0
|
58.1
|
1.0
|
CE1
|
A:TYR59
|
4.0
|
44.7
|
1.0
|
C10
|
A:XZ1201
|
4.1
|
76.6
|
1.0
|
CZ
|
A:TYR59
|
4.1
|
42.3
|
1.0
|
CD
|
A:LYS63
|
4.3
|
49.1
|
1.0
|
O
|
A:HOH343
|
4.3
|
50.1
|
1.0
|
CD2
|
A:LEU156
|
4.4
|
44.0
|
1.0
|
CG1
|
A:ILE106
|
4.4
|
59.7
|
1.0
|
CD1
|
A:LEU156
|
4.4
|
42.0
|
1.0
|
C15
|
A:XZ1201
|
4.5
|
80.8
|
1.0
|
CD1
|
A:ILE106
|
4.5
|
63.8
|
1.0
|
O
|
A:ILE106
|
4.6
|
39.2
|
1.0
|
O
|
A:HOH330
|
4.6
|
0.2
|
1.0
|
CA
|
A:ALA110
|
4.7
|
53.0
|
1.0
|
CE
|
A:LYS63
|
4.8
|
52.6
|
1.0
|
CG2
|
A:ILE106
|
4.8
|
51.2
|
1.0
|
CG
|
A:LEU156
|
5.0
|
44.2
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 6ko9
Go back to
Chlorine Binding Sites List in 6ko9
Chlorine binding site 2 out
of 4 in the Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl201
b:84.5
occ:1.00
|
CL1
|
B:XZ1201
|
0.0
|
84.5
|
1.0
|
C12
|
B:XZ1201
|
1.8
|
64.5
|
1.0
|
C13
|
B:XZ1201
|
2.6
|
58.2
|
1.0
|
F1
|
B:XZ1201
|
2.7
|
52.1
|
1.0
|
C11
|
B:XZ1201
|
2.8
|
55.8
|
1.0
|
CD2
|
B:LEU66
|
3.2
|
56.5
|
1.0
|
CE1
|
B:TYR92
|
3.3
|
47.8
|
1.0
|
CZ
|
B:TYR92
|
3.7
|
47.5
|
1.0
|
CD2
|
B:LEU156
|
3.8
|
51.3
|
1.0
|
CD1
|
B:ILE106
|
3.8
|
56.9
|
1.0
|
OH
|
B:TYR92
|
3.9
|
58.5
|
1.0
|
C14
|
B:XZ1201
|
3.9
|
58.4
|
1.0
|
CD1
|
B:TYR92
|
3.9
|
47.0
|
1.0
|
C10
|
B:XZ1201
|
4.0
|
52.9
|
1.0
|
CG2
|
B:ILE106
|
4.1
|
55.1
|
1.0
|
CE2
|
B:TYR92
|
4.5
|
42.0
|
1.0
|
C15
|
B:XZ1201
|
4.5
|
57.5
|
1.0
|
O
|
B:HOH303
|
4.5
|
50.2
|
1.0
|
NZ
|
B:LYS63
|
4.7
|
51.0
|
1.0
|
CG
|
B:TYR92
|
4.7
|
45.3
|
1.0
|
CG
|
B:LEU66
|
4.7
|
54.2
|
1.0
|
O
|
B:HOH347
|
4.8
|
56.4
|
1.0
|
CG1
|
B:ILE106
|
4.9
|
60.3
|
1.0
|
CD2
|
B:TYR92
|
4.9
|
46.7
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 6ko9
Go back to
Chlorine Binding Sites List in 6ko9
Chlorine binding site 3 out
of 4 in the Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl201
b:85.7
occ:1.00
|
CL1
|
C:XZ1201
|
0.0
|
85.7
|
1.0
|
C12
|
C:XZ1201
|
1.8
|
65.3
|
1.0
|
O
|
C:HOH438
|
1.9
|
85.0
|
1.0
|
C13
|
C:XZ1201
|
2.7
|
59.3
|
1.0
|
C11
|
C:XZ1201
|
2.7
|
59.9
|
1.0
|
O
|
C:HOH355
|
2.8
|
63.6
|
1.0
|
F1
|
C:XZ1201
|
2.9
|
73.7
|
1.0
|
CD2
|
C:LEU66
|
3.3
|
54.4
|
1.0
|
CE1
|
C:TYR92
|
3.4
|
60.5
|
1.0
|
CZ
|
C:TYR92
|
3.7
|
51.7
|
1.0
|
OH
|
C:TYR92
|
3.7
|
38.0
|
1.0
|
CD2
|
C:LEU156
|
3.8
|
39.4
|
1.0
|
O
|
C:HOH312
|
3.8
|
0.7
|
1.0
|
CD1
|
C:ILE106
|
3.9
|
58.3
|
1.0
|
C14
|
C:XZ1201
|
4.0
|
70.8
|
1.0
|
C10
|
C:XZ1201
|
4.0
|
68.8
|
1.0
|
CD1
|
C:TYR92
|
4.1
|
53.3
|
1.0
|
CG2
|
C:ILE106
|
4.4
|
46.8
|
1.0
|
O
|
C:HOH351
|
4.4
|
93.7
|
1.0
|
C15
|
C:XZ1201
|
4.5
|
79.7
|
1.0
|
CE2
|
C:TYR92
|
4.6
|
47.3
|
1.0
|
O
|
C:HOH393
|
4.7
|
0.5
|
1.0
|
CG
|
C:LEU66
|
4.7
|
53.7
|
1.0
|
CG1
|
C:ILE106
|
4.8
|
47.5
|
1.0
|
CG
|
C:TYR92
|
5.0
|
44.5
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 6ko9
Go back to
Chlorine Binding Sites List in 6ko9
Chlorine binding site 4 out
of 4 in the Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of the Gefitinib Intermediate 1 Bound Ramr Determined with Xtalab Synergy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl201
b:72.6
occ:1.00
|
CL1
|
D:XZ1201
|
0.0
|
72.6
|
1.0
|
C12
|
D:XZ1201
|
1.8
|
71.4
|
1.0
|
C13
|
D:XZ1201
|
2.5
|
59.2
|
1.0
|
F1
|
D:XZ1201
|
2.6
|
71.6
|
1.0
|
C11
|
D:XZ1201
|
2.8
|
73.5
|
1.0
|
CB
|
D:ALA110
|
3.4
|
44.9
|
1.0
|
CG1
|
D:ILE106
|
3.7
|
44.0
|
1.0
|
C14
|
D:XZ1201
|
3.8
|
68.4
|
1.0
|
O
|
D:HOH373
|
3.9
|
0.1
|
1.0
|
CE1
|
D:TYR59
|
3.9
|
48.5
|
1.0
|
O
|
D:ILE106
|
4.1
|
44.2
|
1.0
|
C10
|
D:XZ1201
|
4.1
|
67.2
|
1.0
|
CD1
|
D:ILE106
|
4.1
|
45.1
|
1.0
|
OH
|
D:TYR59
|
4.2
|
51.6
|
1.0
|
CD
|
D:LYS63
|
4.2
|
56.9
|
1.0
|
CE
|
D:LYS63
|
4.3
|
61.4
|
1.0
|
CD1
|
D:LEU156
|
4.3
|
39.1
|
1.0
|
CG2
|
D:ILE106
|
4.4
|
46.6
|
1.0
|
C15
|
D:XZ1201
|
4.4
|
74.0
|
1.0
|
CA
|
D:ALA110
|
4.5
|
44.4
|
1.0
|
CD2
|
D:LEU156
|
4.5
|
35.9
|
1.0
|
CZ
|
D:TYR59
|
4.6
|
49.9
|
1.0
|
CB
|
D:ILE106
|
4.6
|
42.9
|
1.0
|
C
|
D:ILE106
|
4.7
|
43.9
|
1.0
|
CD1
|
D:TYR59
|
5.0
|
41.0
|
1.0
|
O
|
D:HOH381
|
5.0
|
0.1
|
1.0
|
|
Reference:
T.Matsumoto,
R.Nakashima,
A.Yamano,
K.Nishino.
Development of A Structure Determination Method Using A Multidrug-Resistance Regulator Protein As A Framework. Biochem.Biophys.Res.Commun. V. 518 402 2019.
ISSN: ESSN 1090-2104
PubMed: 31431261
DOI: 10.1016/J.BBRC.2019.08.070
Page generated: Sun Jul 28 02:30:48 2024
|